Clinical trial · Observational
Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation
Assessing Performance Status in Cancer Patients Using Cardiopulmonary Exercise Testing and Wearable Data Generation: A Prospective Observational Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary objective of this study is to establish the feasibility and value of physical fitness assessment within patients receiving cytotoxic chemotherapy. If successful, this project will establish the groundwork for physical function assessment in larger cancer clinical trials to assist patient selection and evaluation of toxicity and/or response among trial participants.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematologic Malignancies | Hematopoietic and Lymphoid Cell Neoplasm | PROBABILISTIC | 0.70 |
| Malignant Solid Tumor | Malignant Solid Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biometric Devices | Device | — | UNRESOLVED |
| Physical Performance Testing | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Adjuvant and Curative Chemotherapy
- description
- 30 participants. Primarily older (60+ years in age) cancer patients receiving cytotoxic chemotherapy with adjuvant or curative intent. Will undergo both the Physical Performance Testing and Biometric Devices interventions.
- interventionNames
- Device: Biometric Devices
- Other: Physical Performance Testing
- label
- Palliative Chemoteraphy
- description
- 30 participants. Primarily older (60+ years in age) cancer patients receiving cytotoxic chemotherapy with palliative intent. Will undergo both the Physical Performance Testing and Biometric Devices interventions.
- interventionNames
- Device: Biometric Devices
- Other: Physical Performance Testing
Primary outcomes (5)
- measure
- Proportion of patients being approached that agree to participate in the study
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients receiving cytotoxic chemotherapy with at least a 3 week cycle (either adjuvant/curative or palliative) * Age ≥ 18, prioritizing patients ≥ 60 years * At least 6 weeks out from surgical resection * Presence of working email address * Access to internet at home and either access to wireless internet or cellular data reception * Ability to read and understand English * Ability to understand and comply with study procedures Exclusion Criteria: * Dementia, altered mental status, or psychiatric condition that would prohibit the understanding or rendering of informed consent * Contraindication to CPET per standard American Thoracic Society (ATS) guidelines
References
Publications (0)
Data not yet available